{{Rsnum
|rsid=121908764
|Chromosome=7
|Orientation=plus
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene=CFTR
|position=117627664
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|Gene_s=CFTR
}}{{omim
|id=602421
|rsnum=121908764
|variant=0107
}}{{ClinVar
|rsid=121908764
|Reversed=0
|FwdREF=G
|FwdALT=A
|REF=G
|ALT=A
|RSPOS=117267718
|CHROM=7
|dbSNPBuildID=133
|SSR=0
|SAO=0
|VP=0x050068000000000002110100
|GENEINFO=CFTR:1080
|GENE_NAME=CFTR
|GENE_ID=1080
|WGT=0
|VC=SNV
|CLNALLE=1
|CLNHGVS=NC_000007.13:g.117267718G>A
|CLNSRC=CFTR2; OMIM Allelic Variant
|CLNSRCID=W1204X_22251; 602421.0107
|CLNSIG=5
|CLNCUI=C0010674; C0010674
|CLNDBN=Cystic fibrosis
|Disease=Cystic fibrosis
|CLNACC=RCV000007633.3
|Tags=PM;PMC;OTHERKG;LSD;OM
|CLNDSDB=GeneReviews:MedGen:OMIM:Orphanet:SNOMED_CT
|CLNDSDBID=NBK1250:C0010674:219700:586:190905008
}}{{PMID|1867528}} Evaluation of a filtration lymphocytapheresis (LCP) device for use in the treatment of patients with rheumatoid arthritis.